Filed before 2025Filed 17 June 2019
AsclepiX Therapeutics, Inc. has sold $7.74M so far
AsclepiX Therapeutics, Inc., a biotech company based in Baltimore, MD, has sold $7.74M so far in its debt round, according to a filing dated 17 June 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 June 2019
- First filed
- 25 October 2018
- Round
- Debt round (amended filing)
- Amount sold
- $7.74M
- Offering size
- $10M
- Investors so far
- 26
- Based in
- Baltimore, MD
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 53% of the 1,781 tracked raises with an amount filed in 2019, and than 49% of the 146 in biotech.
AsclepiX Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 11 Jun 2020 | New filing | $10M | Another raise |
| 17 Jun 2019 | Amended filing | $7.74M | This raise |
| 25 Oct 2018 | New filing | $3.88M | This raise |
More with Hibiscus Capital Management on the board
- Sendero Biotechnology, Inc.$7.34M
- Contraline, Inc.$7.23M
- Velicept Therapeutics, Inc.$15.5M
- TECTURA Corp$14.8K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.